HW

Henry Walter Gerock Iii

Active Director Additional Director DIN 11354476
DIN 11354476 First appointment Oct 2025 Primary industry Professional Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Henry Walter Gerock Iii

Data last updated:

Henry Walter Gerock Iii is an Additional Director at Ora Clinical Research India Private Limited (since 2025). The company operates in Professional Services.

DIN 11354476
Primary Designation Additional Director
Industry Professional Services
First Appointment 24 Oct 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director24 Oct 20252024Active

Board colleagues of Henry Walter Gerock Iii

Directorship timeline

Open interactive timeline →
Ora Clinical Research India Private Limited
Premium access

Shareholding and investment profile for Henry Walter Gerock Iii

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Henry Walter Gerock Iii

Henry Walter Gerock Iii currently holds 1 directorship: Ora Clinical Research India Private Limited (Additional Director, since 24 Oct 2025).

Henry Walter Gerock Iii was first appointed on 24 Oct 2025 as Additional Director at Ora Clinical Research India Private Limited.

The current boards of Henry Walter Gerock Iii's companies include Govardhan Raghavendra Kulkarni (Ora Clinical Research India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available